• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Catalog Number 1011487-15
Device Problems Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/27/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that the procedure on (b)(6) 2023 was to treat a 70% stenosed lesion in the left vertebral artery ostium.A guide wire was placed and pre-dilatation was performed.The 4.0x15mm herculink elite stent delivery system (sds) was attempted to be advanced to the target lesion; however, failed to advance due to the anatomy.When the sds was being removed to perform additional pre-dilatation, the stent dislodged at the ostium of the vertebral artery.The herculink sds was removed and a 1.5x15mm balloon was used to attempt to remove the stent.The stent was retracted back to the femoral artery, but was not able to be removed with the balloon.The patient had no discomfort and blood flow was smooth.The patient was placed temporarily on anti-platelet medication and monitored.Then, on 10/03/2023 digital subtraction angiography (dsa) was performed and a surgical incision was made to remove the stent.The patient is in good condition.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties and subsequent surgical intervention, unexpected medical intervention (additional therapy/non-surgical treatment), and medication required appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design, or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18132327
MDR Text Key328064239
Report Number2024168-2023-12619
Device Sequence Number1
Product Code NIN
UDI-Device Identifier08717648077838
UDI-Public08717648077838
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/14/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011487-15
Device Lot Number2041161
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-